Biologic evaluation of tumor-associated glycoprotein-72 and carcinoembryonic antigen expression in colorectal cancer, Part I.

Abstract

Tumor-associated glycoprotein-72 has been recently suggested as a new serum marker for colorectal cancer. In fact, approximately 40 percent of colorectal cancer patients have positive tumor-associated glycoprotein-72 serum levels at the time of diagnosis, while only 3 percent of patients with benign diseases are positive. A longitudinal evaluation of… (More)

Topics

Cite this paper

@article{Guadagni1994BiologicEO, title={Biologic evaluation of tumor-associated glycoprotein-72 and carcinoembryonic antigen expression in colorectal cancer, Part I.}, author={Fiorella Guadagni and Mimmo Roselli and Maurizio Cosimelli and Antonella Spila and F. Cavaliere and Roberto Arcuri and Maria Rosaria Abbolito and John W. Greiner and Jeffrey Schlom}, journal={Diseases of the colon and rectum}, year={1994}, volume={37 2 Suppl}, pages={S16-23} }